These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 17976003)

  • 21. Truncation and non-natural amino acid substitution studies on HTLV-I protease hexapeptidic inhibitors.
    Nguyen JT; Zhang M; Kumada HO; Itami A; Nishiyama K; Kimura T; Cheng M; Hayashi Y; Kiso Y
    Bioorg Med Chem Lett; 2008 Jan; 18(1):366-70. PubMed ID: 18006315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The identification of beta-hydroxy carboxylic acids as selective MMP-12 inhibitors.
    Holmes IP; Gaines S; Watson SP; Lorthioir O; Walker A; Baddeley SJ; Herbert S; Egan D; Convery MA; Singh OM; Gross JW; Strelow JM; Smith RH; Amour AJ; Brown D; Martin SL
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5760-3. PubMed ID: 19703773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of amide and heteroaryl isosteres as carbamate replacements in a series of orally active gamma-secretase inhibitors.
    McBriar MD; Clader JW; Chu I; Del Vecchio RA; Favreau L; Greenlee WJ; Hyde LA; Nomeir AA; Parker EM; Pissarnitski DA; Song L; Zhang L; Zhao Z
    Bioorg Med Chem Lett; 2008 Jan; 18(1):215-9. PubMed ID: 17988864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Inhibitors as factors regulating proteolysis].
    Kazanskaia NF
    Bioorg Khim; 1994 May; 20(5):485-91. PubMed ID: 8053943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparative analysis of sensitivity of proteases (chymotrypsin and trypsin) and cholinesterases of different origin to some organophosphorus inhibitors].
    Rozengart EV
    Zh Evol Biokhim Fiziol; 2009; 45(3):277-83. PubMed ID: 19569552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Docking of noncompetitive inhibitors into dengue virus type 2 protease: understanding the interactions with allosteric binding sites.
    Othman R; Kiat TS; Khalid N; Yusof R; Newhouse EI; Newhouse JS; Alam M; Rahman NA
    J Chem Inf Model; 2008 Aug; 48(8):1582-91. PubMed ID: 18656912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improving potency and selectivity of a new class of non-Zn-chelating MMP-13 inhibitors.
    Heim-Riether A; Taylor SJ; Liang S; Gao DA; Xiong Z; Michael August E; Collins BK; Farmer BT; Haverty K; Hill-Drzewi M; Junker HD; Mariana Margarit S; Moss N; Neumann T; Proudfoot JR; Keenan LS; Sekul R; Zhang Q; Li J; Farrow NA
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5321-4. PubMed ID: 19692239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Substituted 2-oxo-azepane derivatives are potent, orally active gamma-secretase inhibitors.
    Kitas EA; Galley G; Jakob-Roetne R; Flohr A; Wostl W; Mauser H; Alker AM; Czech C; Ozmen L; David-Pierson P; Reinhardt D; Jacobsen H
    Bioorg Med Chem Lett; 2008 Jan; 18(1):304-8. PubMed ID: 17983746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.
    Nuti E; Panelli L; Casalini F; Avramova SI; Orlandini E; Santamaria S; Nencetti S; Tuccinardi T; Martinelli A; Cercignani G; D'Amelio N; Maiocchi A; Uggeri F; Rossello A
    J Med Chem; 2009 Oct; 52(20):6347-61. PubMed ID: 19775099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. From lead to preclinical candidate: optimization of beta-homophenylalanine based inhibitors of dipeptidyl peptidase IV.
    Nordhoff S; López-Canet M; Hoffmann-Enger B; Bulat S; Cerezo-Gálvez S; Hill O; Rosenbaum C; Rummey C; Thiemann M; Matassa VG; Edwards PJ; Feurer A
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4818-23. PubMed ID: 19576767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potent pyrrolidine- and piperidine-based BACE-1 inhibitors.
    Iserloh U; Wu Y; Cumming JN; Pan J; Wang LY; Stamford AW; Kennedy ME; Kuvelkar R; Chen X; Parker EM; Strickland C; Voigt J
    Bioorg Med Chem Lett; 2008 Jan; 18(1):414-7. PubMed ID: 18023580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evolution of tertiary carbinamine BACE-1 inhibitors: Abeta reduction in rhesus CSF upon oral dosing.
    Nantermet PG; Rajapakse HA; Stanton MG; Stauffer SR; Barrow JC; Gregro AR; Moore KP; Steinbeiser MA; Swestock J; Selnick HG; Graham SL; McGaughey GB; Colussi D; Lai MT; Sankaranarayanan S; Simon AJ; Munshi S; Cook JJ; Holahan MA; Michener MS; Vacca JP
    ChemMedChem; 2009 Jan; 4(1):37-40. PubMed ID: 19085994
    [No Abstract]   [Full Text] [Related]  

  • 33. Design, synthesis and SAR studies of tripeptide analogs with the scaffold 3-phenylpropane-1,2-diamine as aminopeptidase N/CD13 inhibitors.
    Shang L; Fang H; Zhu H; Wang X; Wang Q; Mu J; Wang B; Kishioka S; Xu W
    Bioorg Med Chem; 2009 Apr; 17(7):2775-84. PubMed ID: 19299146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and structure-activity relationships of potent 4-fluoro-2-cyanopyrrolidine dipeptidyl peptidase IV inhibitors.
    Fukushima H; Hiratate A; Takahashi M; Mikami A; Saito-Hori M; Munetomo E; Kitano K; Chonan S; Saito H; Suzuki A; Takaoka Y; Yamamoto K
    Bioorg Med Chem; 2008 Apr; 16(7):4093-106. PubMed ID: 18243000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis and SAR of potent statine-based BACE-1 inhibitors: exploration of P1 phenoxy and benzyloxy residues.
    Bäck M; Nyhlén J; Kvarnström I; Appelgren S; Borkakoti N; Jansson K; Lindberg J; Nyström S; Hallberg A; Rosenquist S; Samuelsson B
    Bioorg Med Chem; 2008 Nov; 16(21):9471-86. PubMed ID: 18842420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluorinated isatin derivatives. Part 1: synthesis of new N-substituted (S)-5-[1-(2-methoxymethylpyrrolidinyl)sulfonyl]isatins as potent caspase-3 and -7 inhibitors.
    Podichetty AK; Faust A; Kopka K; Wagner S; Schober O; Schäfers M; Haufe G
    Bioorg Med Chem; 2009 Apr; 17(7):2680-8. PubMed ID: 19299147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.
    Li W; Hu Y; Li J; Thomason JR; DeVincentis D; Du X; Wu J; Hotchandani R; Rush TS; Skotnicki JS; Tam S; Chockalingam PS; Morris EA; Levin JI
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4546-50. PubMed ID: 19625186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel 3-phenylpropane-1,2-diamine derivates as inhibitors of aminopeptidase N (APN).
    Shang L; Wang Q; Fang H; Mu J; Wang X; Yuan Y; Wang B; Xu W
    Bioorg Med Chem; 2008 Dec; 16(23):9984-90. PubMed ID: 18996018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rational design and synthesis of potent dibenzazepine motifs as beta-secretase inhibitors.
    Al-Tel TH; Al-Qawasmeh RA; Schmidt MF; Al-Aboudi A; Rao SN; Sabri SS; Voelter W
    J Med Chem; 2009 Oct; 52(20):6484-8. PubMed ID: 19788239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 1-Hydroxy-2-pyridinone-based MMP inhibitors: synthesis and biological evaluation for the treatment of ischemic stroke.
    Zhang YM; Fan X; Chakaravarty D; Xiang B; Scannevin RH; Huang Z; Ma J; Burke SL; Karnachi P; Rhodes KJ; Jackson PF
    Bioorg Med Chem Lett; 2008 Jan; 18(1):409-13. PubMed ID: 17981034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.